Dermatologists.com

Owner white paper

Valuing a Dermatology Practice and Planning the Owner's Exit

Executive summary

A dermatology practice is worth what a qualified buyer can acquire and continue to operate, after accounting for the people, contracts, facilities, equipment, cash needs and risks that travel with the business. A valuation is therefore not a reward for years of work, a multiple copied from a broker's conversation, or the owner's desired retirement number. It is a reasoned estimate tied to a defined transaction, a defined interest and a defined set of assumptions.

For many multi-physician practices, normalized earnings provide a useful starting point. EBITDA means earnings before financing costs and income taxes, with depreciation and amortization added back. Normalization adjusts reported operating results to reflect the cost and conditions a buyer would expect after closing. The key judgment is often owner compensation: what would it cost to replace clinical work and management duties supplied by selling owners? Personal expenses and one-time costs can be considered only when documented, genuinely nonrecurring and unnecessary to keep the practice operating.

The value estimate still needs a method. An income approach examines maintainable cash flow and risk. A market approach compares relevant transactions when reliable, sufficiently similar evidence exists. An asset approach can help when tangible assets, real estate, or a low-earnings situation dominate. Each method answers a different question. A professional may reconcile methods, but an arithmetic average does not cure weak data.

Internal succession can preserve local control and offer an associate a path to ownership, but the purchase price is only one part of the design. Financing, distributions, voting rights and future dilution affect whether a buy-in can work. Outside sales, recapitalizations, continued ownership and an orderly wind-down each solve different owner objectives. Start with the owner's desired role and liquidity, then test which structure can support them.

The figures below are public context, not sale-price evidence. Public wage estimates describe employees, and physician ownership surveys describe practice arrangements. Neither establishes a dermatology practice's EBITDA multiple. The examples in this paper are expressly illustrative and are not market quotes or appraisals.

Key figures

Public figureValueSource and meaning
Dermatologist employment estimate12,040BLS, Dermatologists. Employee estimate; self-employed workers are excluded.
Dermatologist mean annual wage$342,860BLS, Dermatologists. Wage context only, not physician-owner compensation or replacement cost.
Mean annual wage in offices of physicians, dermatologists$347,530BLS, Dermatologists. Industry estimate for employed dermatologists.
Medical assistant mean annual wage$43,350BLS, Medical Assistants. National employee wage estimate, not a local hiring budget.
Medical secretaries and administrative assistants mean annual wage$43,380BLS, Medical Secretaries and Administrative Assistants. Occupational category is broader than dermatology office roles.
Physicians working in private practices42.2%AMA, Physician Practice Characteristics. Survey finding for physicians, not dermatology-specific.
Change in private-practice share18 percentage points lower than the earlier survey measureAMA, Physician Practice Characteristics. The report compares 42.2% with 60.1%; this is context for ownership transitions, not a prediction of sale prospects.

The BLS wage calculations describe employees using a standard full-time work year. They exclude self-employed physicians. Geography and clinical effort affect replacement cost. AMA findings cover physicians across specialties and do not report dermatology-specific sale outcomes.

Analysis

1. Define the interest and the question before asking for a number

An owner can request a valuation for a minority buy-in, estate planning, a partner dispute, financing or an outside sale. These purposes may require different standards of value and investigation. A minority interest with limited control and no route to liquidity differs economically from a controlling interest with authority to sell the whole practice. The engagement letter should state the subject entity, ownership percentage and valuation date. It should also say whether the work is an appraisal, calculation engagement, broker opinion or internal estimate.

Define the assets in scope. The operating company may own equipment and receivables, while a separate entity owns the building. A physician may hold personal goodwill, and a management company may charge fees. State how each entity is treated. Without that perimeter, precise values can refer to different bundles of rights.

Ask the adviser to explain the evidence behind the conclusion. Owners should know which earnings period was used, what was normalized and whether the value assumes a cash-free, debt-free closing. Carry the same definitions through the term sheet and closing statement.

2. Choose methods that fit the practice and the evidence

The income approach estimates the economic value of future benefits. One version capitalizes stable earnings; another forecasts cash flow over a defined period and discounts it for risk. It fits a going concern when records support earnings a buyer expects to continue. Account for capital spending, working capital and the cost of replacing owner labor. EBITDA is a proxy for operating performance, not cash available to equity holders. Debt service, taxes, equipment replacement and growth investment consume cash.

The market approach compares the practice with sales or public-company data. Public-company multiples can be a poor match for an independent medical office because scale differs. Private transaction data may be incomplete or based on another earnings definition. A claimed industry multiple without transaction date and EBITDA definition has little decision value. Ask for each comparator's source and adjustment method.

The asset approach identifies tangible and certain intangible assets and liabilities. It can be relevant to a practice with weak earnings, substantial equipment or real estate, or a potential liquidation. It may understate a profitable going concern if the operating system, assembled team and transferable relationships produce earnings beyond the value of individual assets. Conversely, a list of equipment at original cost does not establish current market value or useful life.

An appraiser can reconcile multiple methods by considering reliability. The analysis should explain why one method deserves greater weight. An earnings forecast supported by records should not automatically receive equal weight with an unsupported comparison from another specialty. Method selection requires professional judgment; combining methods does not create accuracy by itself.

3. Build normalized EBITDA from records, not memory

Start with financial statements reconciled to tax returns and the general ledger. Use several years of history plus a recent interim period. Explain accounting changes, owner distributions booked as expenses and provider departures. Reconcile revenue to collections and payer recoupments. Separate medical dermatology and cosmetic services where records support it.

Prepare an adjustment schedule describing each item and its proposed treatment. Possible adjustments include excess owner compensation or a one-time relocation expense. Test each add-back against the future budget. If the practice still needs the activity after closing, it is not an earnings addition merely because the owner performs it now.

Normalize owner compensation carefully. Separate salary, bonus, benefits, retirement contributions, vehicle costs and related-party payments. Estimate the market cost to replace the actual clinical sessions and management duties, including payroll taxes, benefits, recruiting expense and any locum or interim coverage. If an owner takes $700,000 in total compensation but replacement labor and benefits would cost $500,000, the potential adjustment is the supported $200,000 difference, subject to the accounting and transaction definition. It is not appropriate to add back the full $700,000 and leave the work unstaffed in the forecast.

Consider a practice where reported EBITDA is $2.4 million. The owner identifies $400,000 of possible adjustments. After review, an illustrative buyer accepts $180,000 for compensation above replacement and $25,000 for a documented nonrecurring transaction expense, while rejecting the rest as recurring or unsupported. Illustrative normalized EBITDA is $2.605 million. At hypothetical multiples of 6.0x, 7.0x and 8.0x, the corresponding illustrative enterprise values are $15.63 million, $18.24 million and $20.84 million. Those multiples are arithmetic teaching assumptions only. They are not market findings, an appraisal or a suggested asking range. A $100,000 change in accepted EBITDA changes indicated value by $600,000 at the hypothetical 6.0x multiple. This sensitivity is why clean records and replacement-cost analysis matter.

Scrutinize costs owners sometimes overlook. An owner who manages schedules without compensation or uses aging equipment may create expenses that a buyer will need to incur. Unfilled positions can make trailing payroll look unusually low. Below-market rent from a related property company may require adjustment. Normalization can increase expenses where current costs are unsustainably low.

4. Test whether earnings transfer with the owner

Transferability asks whether another operator can retain revenue and run the practice under the rights and resources available after closing. Map provider-level collections, contribution margin, clinical sessions, tenure, notice terms, ownership and management duties. Identify patients and referral channels associated with a departing physician, but avoid treating any person or relationship as an asset that can be transferred without consent or legal review. The operational question is whether the practice has a credible continuity plan and enough capacity to maintain service.

Review payer assignment provisions, leases and equipment contracts. A buyer may need new credentialing or landlord approval. A short lease can make a location's earnings less secure. Cosmetic services may depend heavily on one clinician or device. A pathology or ancillary business may require separate licenses and compliance review. These details affect due diligence even if the headline multiple is unchanged.

Measure provider concentration in dollars and operating capacity. Calculate each clinician's share of collections, then assess whether another clinician has schedule room to assume work. A founder who accounts for much of revenue creates a succession task. A capable administrator can reduce dependence, but cannot replace physician retention.

5. Translate enterprise value into proceeds and liquidity

Enterprise value describes the operating business before financing claims and certain closing adjustments. Equity value begins with enterprise value, subtracts funded debt and agreed debt-like items, adds cash included in the deal and adjusts for working capital. The purchase agreement defines these categories. Potential debt-like items may include unpaid taxes, transaction bonuses, overdue capital expenses or obligations that function like borrowing. Whether an item belongs in debt, working capital or ordinary operations must be negotiated and consistently applied.

Illustrative bridge: an $18 million enterprise value, less $2 million of debt, plus $300,000 of excess cash, less a $250,000 working-capital shortfall and $400,000 of transaction expenses, produces $15.65 million before taxes, escrow, rollover equity and other agreed terms. If the seller retains a $3 million investment in the buyer and $1 million is held in escrow, cash received at closing is lower. The illustration assumes those amounts and classifications; actual agreements often define cash, working capital and expenses differently.

Model consideration as well as price. Cash at closing, seller notes, earn-outs, rollover equity and escrow carry different risks. A seller note depends on the buyer's ability to pay. An earn-out may depend on decisions controlled by the buyer. Rollover value remains exposed to the future business and may not be liquid when desired. Compare after-tax proceeds and post-closing duties, not only headline value.

6. Design an internal buy-in that the associate can finance

An internal transaction can occur through a purchase of existing shares, issuance of new shares, or a combination. A sale gives proceeds to the selling owner. A new issuance puts capital into the practice but dilutes existing owners. The documents should state the ownership percentage before and after the transaction, voting rights and distribution policy. The valuation mechanism must specify whether it applies to the whole enterprise, equity after debt, or the particular interest being transferred.

Consider an illustrative 20% purchase of equity valued at $4 million, producing an $800,000 price before adjustments. If financed over five years at a hypothetical 6% interest rate with level annual payments, annual debt service is about $190,000. This is a mathematical illustration, not a lender offer. The associate needs cash flow after taxes and compensation to support the debt. The selling owner needs to evaluate credit risk, security and default remedies, including whether the practice can function if the buyer leaves.

Avoid a formula that is easy to calculate but disconnected from economic reality. Revenue alone ignores margins and debt. Book value may miss a profitable going concern. A fixed price can become stale after a major acquisition or provider departure. A formula can use normalized EBITDA with agreed adjustments, a qualified independent appraisal, or a hybrid process with a defined dispute mechanism. Specify data access, appraisal selection, valuation date, treatment of minority interests and the procedure if the parties cannot agree.

The governance transition deserves equal attention. Set thresholds for budgets, borrowing, owner compensation, distributions, hiring, new locations, major contracts and a sale of the business. Decide how capital calls are approved and what happens if one owner cannot contribute. Address death, disability, retirement, divorce, misconduct, license restrictions, voluntary departure and termination. Give the remaining owners a workable purchase right and payment period; a mandatory lump sum can overwhelm the business precisely when an owner exits unexpectedly.

7. Compare succession and exit paths against the owner's actual priorities

An associate buy-in can preserve physician ownership and reward a successor who already understands the practice. It may take years, produce gradual liquidity and require the seller to remain clinically or administratively active. The incoming owner may need outside financing or seller financing, and both parties must be comfortable sharing authority during the transition. A staged transfer can match responsibility to experience, provided each stage has a price and a decision rule.

An outside sale to another practice, hospital, management company or financial sponsor can create more immediate liquidity or provide infrastructure. It can also involve deeper diligence, integration requirements, employment terms, noncompetition provisions, rollover capital and less control over operations. Buyers may value the practice differently depending on their strategy and capacity to integrate it. Owners should request written proposals with comparable definitions of cash, contingent payments, working capital and post-closing obligations.

A recapitalization sells a portion of ownership while the owner retains a stake or leadership role. It can provide partial liquidity while leaving the owner exposed to execution risk. Continued ownership with a managing physician may fit owners who want a reduced schedule. A wind-down can be responsible when no successor or buyer can support the obligations, though it requires plans for staff and liabilities.

Before a process begins, write down the desired clinical schedule, decision authority, timing of cash, tolerance for contingent value, staff priorities and willingness to stay after closing. Rank those terms. A buyer proposal that maximizes value but requires an unwanted employment commitment may not satisfy the owner's objective. A lower cash price with a clear transition and fewer contingencies may be preferable for another owner. The comparison should be explicit and individual.

8. Prepare the practice before the owner is under pressure

Readiness work improves planning and buyer diligence. Keep monthly statements and a clean general ledger; reconcile deposits; document owner compensation; maintain provider agreements; track leases and capital spending; retain ownership records. Build a dashboard for collections, accounts receivable, provider capacity and service-line contribution. Explain unusual results before a buyer has to interpret them.

Create a succession file with the operating agreement, buy-sell documents, entity chart and debt schedule. Share confidential information through controlled diligence. Set a timeline for valuation and transition planning. Coordinate estate documents and insurance with buy-sell terms so funding matches obligations.

Owner implications

Treat value as a range with assumptions, not a single promise. A useful planning range shows which changes in normalized EBITDA, accepted adjustments, transfer risk and deal terms drive the result. Keep the range separate from a lender's collateral view, a tax position and a partner's contractual buyout formula; they may serve different purposes and follow different rules.

For a dermatology group, the owner should be able to explain how clinical production becomes collected revenue, which staff and sites support it, what owner labor costs to replace, and how the practice would retain clinicians and key contracts after transition. If the story depends on undocumented exceptions, deal preparation should begin with the records. If the underlying operation depends on a founder, succession design should address that dependency before a sale process.

Select advisers for the work they will perform. A valuation professional should explain credentials, scope and independence. Legal counsel should review ownership and employment issues under applicable law. Tax counsel should model the entity and transaction structure. An investment banker or broker can test buyer interest, but the owner should understand compensation and whom the adviser represents. A lender can assess financeability; that is not the same as determining fair value.

Action checklist

Sources

Scope and limitations

This paper is general business education for dermatology practice owners. It is not an appraisal, fairness opinion, legal or tax opinion, financing offer, transaction recommendation or forecast. The public figures describe workforce and ownership patterns, not private sale prices. BLS figures exclude self-employed workers and may not reflect local recruitment conditions. AMA survey results cover physicians across specialties and do not establish a dermatology-specific pattern. Illustrative numbers are invented for explanation and should not be treated as market evidence. Any valuation or transfer decision requires current practice records, a defined purpose and advice from qualified professionals familiar with the relevant jurisdiction and transaction.

Questions? Contact Richard@DoctorsInvestorClub.com.

Education only. This material is for general informational purposes and is not financial, investment, legal, tax, accounting or valuation advice. Consult advisers who can review the practice's records and circumstances before making a transaction or succession decision.

Richard C. Wilson

Backed by Richard C. Wilson and Family Office Club, the largest investor club in the world by media reach

  • $1B+In deals closed between members
  • 17MRegistered members across our networking groups
  • 19MSocial media followers
  • 340+Events hosted since 2007
  • 16In-person events a year
  • 50AI tools built on what works with family offices and investors

Family Office Club network figures. They describe the organization and its members, not a promise of investment or transaction results.